{"id":1479,"date":"2020-05-07T21:48:00","date_gmt":"2020-05-08T01:48:00","guid":{"rendered":"http:\/\/www.spartasystems.com\/?post_type=resources&p=1479"},"modified":"2022-04-20T11:42:00","modified_gmt":"2022-04-20T15:42:00","slug":"quality-management-as-a-strategic-technology-partner","status":"publish","type":"resources","link":"https:\/\/www.spartasystems.com\/resources\/quality-management-as-a-strategic-technology-partner\/","title":{"rendered":"The three pillars of the Life Sciences industry"},"content":{"rendered":"\n

Elevating the role of the technology solution provider in service of the health and wellness of the global population<\/h2>\n\n\n\n

The Dilemma for Quality Leaders<\/strong>
Quality Management System (QMS) process complexity and variability is an industry-wide, systematic problem that brings a heavy burden of cost and risk. The pace of innovation and disruptive nature of novel product are equally both exciting and challenging from a quality enablement perspective.

The patient is becoming the center of the universe that the life sciences supply chain serves. The line separating that supply chain from the broader healthcare ecosystem blurs through this growing trend of patient-centricity.

That same supply chain becomes ever more complex as it is increasingly virtualized and outsourced. Simultaneously, the volume of acquisition and divestiture in the space continue to rise.

Much of this is driven by the reality that is Industry 4.0. This makes even measuring total cost of quality (TCoQ), let alone controlling or decreasing it, a far important and difficult endeavor. These macro trends sum up well, Mode 2 of the bi-modal challenge<\/a> faced by industry today as it pulls in opposition to the day-to-day micro challenges of Mode 1.

And if this outlines Mode 2, Mode 1 can be well characterized by the five key imperatives front and center in the minds every quality leader on a daily basis:<\/p>\n\n\n\n